产科麻醉与围产医学会等关于阿片类药物使用障碍孕妇疼痛管理的共识声明
该多学科共识声明由SOAP、SMFM和ASRA联合制定,针对阿片类药物使用障碍(OUD)的妊娠及产后患者,提供疼痛管理框架。内容涵盖产前疼痛管理优化、分娩镇痛、阴道分娩后及剖宫产术后疼痛管理,讨论非药物与药物选项、OUD药物管理(如丁丙诺啡、美沙酮)、尿液药物检测及母婴二元社会关怀,并给出循证建议以优化疼痛管理并降低OUD相关风险。
要点
- OUD孕妇疼痛管理需平衡阿片耐受、戒断或复吸风险与充分镇痛。
- 共识涵盖产前优化、分娩镇痛及产后(阴道/剖宫产)疼痛管理。
- 推荐涉及非药物/药物选项、OUD药物管理及尿液检测等社会因素。
核心结论
- 多学科共识声明为OUD妊娠患者提供实用循证建议以优化疼痛管理并改善母婴结局。
研究设计与样本
- 由SOAP、SMFM和ASRA联合制定的多学科共识声明,面向产科和麻醉科医护人员。
主要发现
- 声明聚焦产前疼痛管理优化、分娩镇痛、阴道分娩后及剖宫产术后疼痛管理。
- 讨论非药物和药物疼痛管理选项、OUD药物管理(如丁丙诺啡、美沙酮)及尿液药物检测。
- 涉及母婴二元社会关怀方面及当前实践回顾。
关键数值与推荐
- 推荐涉及非药物和药物疼痛管理选项、OUD药物管理(如丁丙诺啡、美沙酮)及尿液药物检测。
临床怎么用
- 临床医生可依据共识对OUD孕妇进行产前疼痛管理优化、分娩镇痛及产后疼痛管理。
- 应综合考虑阿片耐受、戒断/复吸风险及母婴社会需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pain management in pregnant and postpartum people with an opioid-use disorder (OUD) requires a balance between risks associated with opioid tolerance, including withdrawal or return to opioid use, considerations around social needs of the maternal-infant dyad, and the provision of adequate pain relief for the birth episode that is often characterized as the worst pain a person will experience in their lifetime. This multidisciplinary consensus statement between the Society for Obstetric Anesthesia and Perinatology (SOAP), Society for Maternal-Fetal Medicine (SMFM), and American Society of Regional Anesthesia and Pain Medicine (ASRA) provides a framework for pain management in obstetric patients with OUD. The purpose of this consensus statement is to provide practical and evidence-based recommendations and is targeted to health care providers in obstetrics and anesthesiology. The statement is focused on prenatal optimization of pain management, labor analgesia, and postvaginal delivery pain management, and postcesarean delivery pain management. Topics include a discussion of nonpharmacologic and pharmacologic options for pain management, medication management for OUD (eg, buprenorphine, methadone), considerations regarding urine drug testing, and other social aspects of care for maternal-infant dyads, as well as a review of current practices. The authors provide evidence-based recommendations to optimize pain management while reducing risks and complications associated with OUD in the peripartum period. Ultimately, this multidisciplinary consensus statement provides practical and concise clinical guidance to optimize pain management for people with OUD in the context of pregnancy to improve maternal and perinatal outcomes.
引用
- Lim G, Carvalho B, George RB, et al. Consensus Statement on Pain Management for Pregnant Patients with Opioid-Use Disorder from the Society for Obstetric Anesthesia and Perinatology, Society for Maternal-Fetal Medicine, and American Society of Regional Anesthesia and Pain Medicine. Anesth Analg. 2024. PMID: 39504271. doi:10.1213/ANE.0000000000007237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。